RACHELLE DOODY to Drug Industry
This is a "connection" page, showing publications RACHELLE DOODY has written about Drug Industry.
Connection Strength
0.260
-
Developing Disease-Modifying Treatments in Alzheimer's Disease - A Perspective from Roche and Genentech. J Prev Alzheimers Dis. 2017; 4(4):264-272.
Score: 0.138
-
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors. Alzheimers Dement. 2009 Mar; 5(2):122-4.
Score: 0.080
-
Report of the task force on designing clinical trials in early (predementia) AD. Neurology. 2011 Jan 18; 76(3):280-6.
Score: 0.023
-
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement. 2009 Mar; 5(2):85-92.
Score: 0.020